NAT10 and head and neck squamous cell carcinoma: To further investigate the clinical relevance of NAT10 in metastatic HNSCC, 43 cases of HNSCC primary tumor tissues and paired lymph node samples and adjacent non-tumor specimens were collected, and the expression levels of NAT10 were assessed.